Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19733 | 491 | 45.6 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
578 | 3 | CHEMOKINES//CXCR4//MACROPHAGE MIGRATION INHIBITORY FACTOR | 16225 |
546 | 2 | CHEMOKINES//CXCR4//CHEMOKINE RECEPTOR | 14674 |
19733 | 1 | CCR2 ANTAGONIST//CCR2//CCR1 | 491 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CCR2 ANTAGONIST | authKW | 1106295 | 5% | 68% | 26 |
2 | CCR2 | authKW | 610336 | 12% | 17% | 57 |
3 | CCR1 | authKW | 426405 | 5% | 29% | 24 |
4 | CCR1 ANTAGONIST | authKW | 222101 | 1% | 71% | 5 |
5 | AZD 4818 | authKW | 186567 | 1% | 100% | 3 |
6 | EXPT STN E336 | address | 139924 | 1% | 75% | 3 |
7 | CC CHEMOKINE RECEPTOR 1 ANTAGONIST | authKW | 124378 | 0% | 100% | 2 |
8 | CP 481715 | authKW | 124378 | 0% | 100% | 2 |
9 | CYCLOPENTABFURAN | authKW | 124378 | 0% | 100% | 2 |
10 | DOCKING EVALUATION | authKW | 124378 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 5496 | 19% | 0% | 95 |
2 | Chemistry, Medicinal | 4291 | 28% | 0% | 137 |
3 | Immunology | 731 | 20% | 0% | 97 |
4 | Chemistry, Organic | 458 | 15% | 0% | 74 |
5 | Pharmacology & Pharmacy | 325 | 17% | 0% | 84 |
6 | Medicine, Research & Experimental | 43 | 5% | 0% | 23 |
7 | Pathology | 28 | 3% | 0% | 14 |
8 | Cell Biology | 10 | 4% | 0% | 22 |
9 | Crystallography | 9 | 2% | 0% | 9 |
10 | Biochemical Research Methods | 7 | 2% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT STN E336 | 139924 | 1% | 75% | 3 |
2 | I SMALL | 124378 | 0% | 100% | 2 |
3 | MED CHEM P INFLAMMAT AUTOIMMUN INNOVAT | 124378 | 0% | 100% | 2 |
4 | PREPARAT SEPARAT TECH | 124378 | 0% | 100% | 2 |
5 | HIGH OUTPUT SYNTH | 82917 | 0% | 67% | 2 |
6 | CLIN IMMUNOL RHEUMATOL F4 218 | 79954 | 1% | 43% | 3 |
7 | AIDS HIV1 INFECT | 62189 | 0% | 100% | 1 |
8 | BIOL PARIS SEINE IBPS 3631 | 62189 | 0% | 100% | 1 |
9 | CAS FOOD SAFETY | 62189 | 0% | 100% | 1 |
10 | CECILE VOGT CLIN NEUROL | 62189 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARTHRITIS RESEARCH | 12290 | 1% | 3% | 6 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 10106 | 13% | 0% | 64 |
3 | EXPERT OPINION ON THERAPEUTIC PATENTS | 8058 | 3% | 1% | 17 |
4 | ARTHRITIS AND RHEUMATISM | 3763 | 5% | 0% | 25 |
5 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 1408 | 1% | 0% | 7 |
6 | ARTHRITIS RESEARCH & THERAPY | 1207 | 2% | 0% | 8 |
7 | ACS MEDICINAL CHEMISTRY LETTERS | 1123 | 1% | 0% | 5 |
8 | ANNUAL REPORTS IN MEDICINAL CHEMISTRY | 1111 | 1% | 0% | 4 |
9 | CURRENT TOPICS IN MEDICINAL CHEMISTRY | 978 | 1% | 0% | 6 |
10 | PHARMACOLOGICAL REVIEWS | 794 | 1% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CCR2 ANTAGONIST | 1106295 | 5% | 68% | 26 | Search CCR2+ANTAGONIST | Search CCR2+ANTAGONIST |
2 | CCR2 | 610336 | 12% | 17% | 57 | Search CCR2 | Search CCR2 |
3 | CCR1 | 426405 | 5% | 29% | 24 | Search CCR1 | Search CCR1 |
4 | CCR1 ANTAGONIST | 222101 | 1% | 71% | 5 | Search CCR1+ANTAGONIST | Search CCR1+ANTAGONIST |
5 | AZD 4818 | 186567 | 1% | 100% | 3 | Search AZD+4818 | Search AZD+4818 |
6 | CC CHEMOKINE RECEPTOR 1 ANTAGONIST | 124378 | 0% | 100% | 2 | Search CC+CHEMOKINE+RECEPTOR+1+ANTAGONIST | Search CC+CHEMOKINE+RECEPTOR+1+ANTAGONIST |
7 | CP 481715 | 124378 | 0% | 100% | 2 | Search CP+481715 | Search CP+481715 |
8 | CYCLOPENTABFURAN | 124378 | 0% | 100% | 2 | Search CYCLOPENTABFURAN | Search CYCLOPENTABFURAN |
9 | DOCKING EVALUATION | 124378 | 0% | 100% | 2 | Search DOCKING+EVALUATION | Search DOCKING+EVALUATION |
10 | INCB3344 | 124378 | 0% | 100% | 2 | Search INCB3344 | Search INCB3344 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CARTER, PH , (2013) PROGRESS IN THE DISCOVERY OF CC CHEMOKINE RECEPTOR 2 ANTAGONISTS, 2009-2012.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 23. ISSUE 5. P. 549 -568 | 60 | 67% | 8 |
2 | SZEKANECZ, Z , KOCH, AE , (2016) SUCCESSES AND FAILURES OF CHEMOKINE-PATHWAY TARGETING IN RHEUMATOID ARTHRITIS.NATURE REVIEWS RHEUMATOLOGY. VOL. 12. ISSUE 1. P. 5 -13 | 49 | 46% | 6 |
3 | KOCH, AE , TAK, PP , SZEKANECZ, Z , (2011) CHEMOKINE AND CHEMOKINE RECEPTOR BLOCKADE IN ARTHRITIS, A PROTOTYPE OF IMMUNE-MEDIATED INFLAMMATORY DISEASES.NETHERLANDS JOURNAL OF MEDICINE. VOL. 69. ISSUE 9. P. 356 -366 | 67 | 37% | 17 |
4 | PEASE, JE , HORUK, R , (2009) CHEMOKINE RECEPTOR ANTAGONISTS: PART 1.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 19. ISSUE 1. P. 39-58 | 50 | 42% | 74 |
5 | LIU, JQ , MERRITT, JR , (2010) CC CHEMOKINE RECEPTOR SMALL MOLECULE ANTAGONISTS IN THE TREATMENT OF RHEUMATOID ARTHRITIS AND OTHER DISEASES: A CURRENT VIEW.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 13. P. 1250-1267 | 45 | 51% | 6 |
6 | CAVALLARO, CL , BRICENO, S , CHEN, J , CVIJIC, ME , DAVIES, P , HYNES, J , LIU, RQ , MANDLEKAR, S , ROSE, AV , TEBBEN, AJ , ET AL (2012) DISCOVERY AND LEAD OPTIMIZATION OF A NOVEL SERIES OF CC CHEMOKINE RECEPTOR 1 (CCR1)-SELECTIVE PIPERIDINE ANTAGONISTS VIA PARALLEL SYNTHESIS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 22. P. 9643 -9653 | 24 | 86% | 3 |
7 | ZHANG, PL , DAIRAGHI, DJ , JAEN, JC , POWERS, JP , (2013) RECENT ADVANCES IN THE DISCOVERY AND DEVELOPMENT OF CCR1 ANTAGONISTS.ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48. VOL. 48. ISSUE . P. 133-147 | 29 | 63% | 1 |
8 | SOBHIA, ME , SINGH, R , KARE, P , CHAVAN, S , (2010) RATIONAL DESIGN OF CCR2 ANTAGONISTS: A SURVEY OF COMPUTATIONAL STUDIES.EXPERT OPINION ON DRUG DISCOVERY. VOL. 5. ISSUE 6. P. 543-557 | 36 | 51% | 7 |
9 | ZHANG, XQ , HUFNAGEL, H , HOU, CF , OPAS, E , MCKENNEY, S , CRYSLER, C , O'NEILL, J , JOHNSON, D , SUI, ZH , (2011) DESIGN, SYNTHESIS AND SAR OF INDAZOLE AND BENZOISOXAZOLE CONTAINING 4-AZETIDINYL-1-ARYL-CYCLOHEXANES AS CCR2 ANTAGONISTS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 21. ISSUE 20. P. 6042 -6048 | 25 | 71% | 8 |
10 | CARTER, PH , (2010) SPIROINDENES AND SPIROINDANES AS ANTAGONISTS OF CC CHEMOKINE RECEPTOR 2: WO 2009023754.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 20. ISSUE 2. P. 283-289 | 24 | 77% | 2 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 14960 | CHEMOKINES//CHEMOKINE RECEPTOR//EXPT CLIN NEUROL |
2 | 7432 | BB 10010//CCL2//LEUKOTACTIN 1 |
3 | 18490 | CHEMOKINE STRUCTURE//LYMPHOTACTIN//CYTOKINE RECEPTOR INTERACTIONS |
4 | 15178 | MONOCYTE CHEMOATTRACTANT PROTEIN 1//MCP 1//MCP 1 POLYMORPHISM |
5 | 10205 | CXCR3//CXCL10//CXCL9 |
6 | 15536 | TARC//THYMUS AND ACTIVATION REGULATED CHEMOKINE//CCR4 |
7 | 21780 | DARC//DUFFY BLOOD GROUP//DUFFY ANTIGEN |
8 | 23275 | SYNOVIAL BIOPSY//SYNOVIAL TISSUE//SYNOVIAL BIOMARKERS |
9 | 16547 | CCL20//CCR6//CCL21 |
10 | 7041 | INTERLEUKIN 8//CXCR2 ANTAGONIST//CXCR2 |